Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Other Non-current Assets

Long-term assets not reported separately.

Organigram Global Inc.NASDAQ: OGI

Other Non-current Assets · Q2 FY2026 · quarter ended Mar 2026

Other non-current assets falls 76.7% from a year ago

Other non-current assets stood at CA$1.52M at the end of Q2 FY2026, down 76.7% from a year earlier and down 23.0% from the prior quarter.

Context

  • Other non-current assets amounted to 0.3% of total assets at the end of Q2 FY2026, down 0.9 pp from a year earlier.
  • Other non-current assets increased in 1 of the last 3 fiscal years.

What to watch

Whether other non-current assets keeps falling in the next quarterly balance sheet after a -76.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$1.52M-23.0% QoQ
Last fiscal yearSep 2025
CA$3.75M+535.2% YoY
Year agoMar 2025
CA$6.51M-76.7% since
Other Non-current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-76.7%——
1 year+535.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Non-current Assets history

CAD · from the balance sheet

Latest · FY2025
3.75M CAD
Year-over-year change
+535.2%
4-year CAGR
-41.1%

Other Non-current Assets vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-current assets is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -76.7% is the lowest of 7, against a peer median of +4.7%.
  • Other non-current assets amounts to 0.3% of total assets for OGI, versus a peer median of 1.3%.
OGI Competitors
Other Non-current Assets for OGI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
INFUInfuSystem Holdings, Inc.Mar 2026$40.34M USD+204.9%—40.9%
LFCRLifecore Biomedical, Inc.Dec 2025$8.7M USD——3.7%
RNACCartesian Therapeutics, Inc.Mar 2026$5.55M USD-28.1%+320.6%1.9%
ACBAurora Cannabis Inc.Mar 2026CA$3.63M CAD-52.8%-38.8%0.6%
OGIOrganigram Global Inc.Mar 2026CA$1.52M CAD-76.7%—0.3%
OBIOOrchestra BioMed Holdings, Inc.Mar 2026$1.26M USD-1.6%-35.9%1.3%
ELMDElectromed, Inc.Mar 2026$1.22M USD+2878.0%-72.5%2.1%
IVAInventiva S.A.Dec 2025€1.16M EUR+11.0%+6.3%0.5%
HSDTSolana CompanyMar 2026$68K USD——0.0%
DERMJourney Medical CorporationMar 2026$0 USD——0.0%
Peer median (excluding OGI) —+4.7%-35.9%1.3%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Cash & Equivalents55.37M68.52M33.86M106.75M28.2M
Short-term Investments128.48M30.4M0821K826K
Net Receivables21M46.37M27.46M37.15M64.86M
Inventory48.82M68.28M80.95M82.52M123.95M
Other Current Assets5.51M2.21M13.7M25.86M55.39M
Total Current Assets260.62M221.62M155.98M262.22M284.9M
Property, Plant & Equipment (Net)235.94M259.82M99.05M96.23M122.98M
Goodwill14.32M41.98M0052.52M
Intangible Assets2.73M14.26M10.62M8.09M48.51M
Long-term Investments6.11M7.07M13.72M40.73M49.55M
Tax Assets3.2M0000
Other Non-current Assets31.11M32.36M19.09M591K3.75M
Total Non-current Assets293.4M355.48M142.48M145.64M277.31M
Total Assets554.02M577.11M298.46M407.86M562.21M
Account Payables18.95M40.86M14.73M47.1M89.25M
Short-term Debt80K80K76K60K25K
Tax Payables01.42M94K00
Deferred Revenue02.44M000
Other Current Liabilities6.25M12M2.35M5.14M35.91M
Total Current Liabilities26.27M55.29M22.43M53.32M126.16M
Long-term Debt230K155K3.63M25K0
Deferred Tax Liabilities03.62M000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities43.07M7.79M771K45.18M79.17M
Total Non-current Liabilities47.95M13.76M4.4M48.55M86.92M
Total Liabilities74.21M69.05M26.83M101.87M213.08M
Common Stock730.8M769.73M776.91M852.89M919.91M
Retained Earnings(275.64M)(289.93M)(538.53M)(583.97M)(608.73M)
Accumulated OCI24.65M28.26M33.25M37.07M37.95M
Other Stockholders Equity00000
Minority Interest00000
Total Equity479.81M508.06M271.62M305.99M349.13M
Total Debt5.95M3.36M3.71M4.46M8.75M
Net Debt(49.42M)(65.16M)(30.16M)(102.29M)(19.45M)

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.